Mild Cognitive Impairment (MCI) marks a critical stage preceding Alzheimer's Disease and other types of dementia. It involves subtle changes in cognitive functions like memory and reasoning that exceed normal age-related decline. While individuals with MCI may struggle with remembering recent events or making decisions, these challenges typically do not significantly disrupt daily life.
Understanding MCI's significance lies in its potential progression to dementia, although this progression isn't inevitable. Some individuals with MCI remain stable or may even show improvement over time. Early detection and intervention are vital, as lifestyle adjustments, cognitive training, and certain medications could potentially slow down or manage further cognitive decline.
Ongoing research aims to deepen our understanding of MCI's origins, risk factors, and effective interventions, with the goal of improving outcomes and enhancing the quality of life for individuals at risk of developing dementia.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States